The usefulness of timed motor tests in assessing Parkinson's disease;Utilidad de los test motores cronometrados en la evaluación de la enfermedad de parkinson

Revista de Neurologia

Volumn 48, Issue 12, 2009, Pages 617-619

  García Ruiz Espiga, Pedro J ^a   Sanchez Bernardos V ^a   Cabo Lopez I ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BODY POSTURE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; DIAGNOSTIC VALUE; FEMALE; FUNCTIONAL ASSESSMENT; HAND MOVEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; ONSET AGE; PARKINSON DISEASE; RATING SCALE; STANDARD; TIME; TIMED TEST; UNIFIED PARKINSON DISEASE RATING SCALE; WALKING; MIDDLE AGED; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS; PARKINSON DISEASE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 68949218355     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4812.2008729     Document Type: Article

References (23)

1. Lang AE, Fahn S. Assessment of Parkinson's disease. In Munsat TL ed. Quantification of neurological deficit. Boston: Butterworth-Heinemann; 1989. p. 285-309.
2. Martínez-Martín P, Gil-Nagel A, Gracia LM, Gómez JB, Martínez-Sarriés J, Bermejo F. Unified Parkinson's Disease Rating Scale, characteristics and structure. Mov Disord 1994; 9: 76-83. (Pubitemid 24022618)
3. Richards M, Marder K, Cote L, Mayeux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord 1994; 9: 89-91. (Pubitemid 2023685)
4. Martínez-Martín P, Frades-Payo B, Rodríguez- Blázquez C, Forjaz MJ, De Pedro-Cuesta J, Grupo de Estudio Longitudinal de Pacientes con Enfermedad de Parkinson (ELEP). Atributos psicométricos de la Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), versión en castellano. Rev Neurol 2008; 47: 337-343
5. Metman LV, Myre B, Verwey N, Hassin-Baer S, Arzbaecher J, Sierens D, et al. Test-retest reliability of UPDRS-III, dyskinesias scales, and timed tests in patients with advanced Parkinson's disease. Mov Disord 2004; 19: 1079-1084
6. Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, et al. The role of radiotracer imaging in Parkinson disease. Neurology 2005; 64: 208-215
7. Eshuis SA, Maguire RP, Leenders KL, Jonkman S, Jager PL. Comparison of FP-CIT SPECT with F-dopa PET in patients with de novo and advanced Parkinson's disease. Eur J Nucl Med Mol Imaging 2006; 33: 200-209 (Pubitemid 43152888)
8. Van Hilten JJ, Braat EA, Van der Velde EA, Middelkoop HA, Van Dijk JG, Lighart GJ, et al. Hypokinesia in Parkinson's disease: influence of age, disease severity and disease duration. Mov Disord 1995; 10: 424-432
9. Dunnewold RJ, Hoff JI, Van Pelt HC, Fredrikze PQ, Wagemans EA, Van Hilten BJ. Ambulatory quantitative assessment of body position, bradykinesia, and hypokinesia in Parkinson's disease. J Clin Neurophysiol 1998; 15: 235-242
10. Hoff J L, Van der Meer V, Van Hilten J. Accuracy of objective ambulatory accelerometry in detecting motor complications in patients with Parkinson's disease. Clin Neuropharmacol 2004; 27: 53-57 (Pubitemid 38569175)
11. Vingerhoets FJ, Schulzer M, Calne DB, Snow BJ. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann Neurol 1997; 41: 58-64.
12. CAPIT committee. Core assessment program for intracerebral transplantation. Mov Disord 1992; 7: 2-13.
13. Muller T, Schafer S, Kuhn W, Przuntek H. Correlation between tapping and inserting of pegs in Parkinson's disease. Can J Neurol Sci 2000; 27: 311-315
14. Brusse KJ, Zimdars S, Zalewski K, Steffen T. Testing functional performance in people with Parkinson's disease. Phys Ther 2005; 85: 134-141
15. Taylor-Tavares AL, Jefferis GS, Koop M, Hill BC, Hastie T, Heit G, et al. Quantitative measurements of alternating finger tapping in Parkinson's disease correlate with UPDRS motor disability and reveal the improvement in fine motor control from medication and deep brain stimulation. Mov Disord 2005; 20: 1286-1298 (Pubitemid 41645903)
16. Muller T, Benz S. Quantification of the dopaminergic response in Parkinson's disease. Parkinsonism Relat Disord 2002; 8: 181-186 (Pubitemid 33089332)
17. Hugues AJ, Daniel SE, Kilford L, Lees A. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184
18. García-Ruiz PJ, Gómez-Tortosa E, Sánchez-Bernardos V, Rojo A, Fontán A, García de Yébenes J. Bradykinesia in Huntington's disease. Clin Neuropharmacol 2000; 23: 50-52
19. García-Ruiz PJ, Hernández J, Cantarero S, Bartolomé M, Sánchez-Bernardos V, García de Yébenes J. Bradykinesia in Huntington's disease. A prospective, follow-up study. J Neurol 2002; 249: 437-440 (Pubitemid 34304618)
20. Lang AE, Benabid AL, Koller WC, Lozano AM, Obeso JA, Olanow CW, et al. The core assessment program for intracerebral transplantation. Mov Disord 1995; 10: 527-529
21. García-Ruiz PJ, Muñiz de Igneson J, Ayerbe J, Frech F, Sánchez-Bernardos V, López-Ferro O, et al. Evaluation of timed tests in advanced parkinsonian patients candidates for subthalamic stimulation. Clin Neuropharmacol 2005; 28: 15-17
22. Pal PK, Lee CS, Samii A, Schulzer M, Stoessl AJ, Mak EK, et al. Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET. Parkinsonism Relat Disord 2001; 7: 305-309 (Pubitemid 32409972)
23. Martínez-Martín P, Carroza-García E, Frades-Payo B, Rodríguez-Blázquez C, Forjaz MJ, De Pedro-Cuesta J, en nombre del Grupo ELEP. Atributos psicométricos de la Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validación en España y revisión. Rev Neurol 2009 [in press].